explore -WSS

explore

author：Wikipedia 2025-10-02 18:49:47 - browse：65

Why are addiction treatments so hard to get? Can small companies compete in obesity? And since when is “Series E” a thing in biotech?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. For the entirety of the opioid overdose epidemic, the U.S. has had readily available tools that are proven to save lives. STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

For more on what we cover, here’s the story on addiction medicine; here’s the latest on biotech financing; here’s more on Novo Nordisk’s oral obesity treatment; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Can we make enough H5N1 bird flu vaccine if there's a pandemic?

WSS

Medicaid rebukes states for mistakenly disenrolling children

Stem cell treatment guidelines are released by FDA

Cytokinetics CEO stresses company can launch heart drug on its own

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

The 10 drugs up first for Medicare price negotiation

Readers respond to H5N1 and livestock movements, and more

hotspot

explore

knowledge

At least 13 dead in Texas as scorching temps continue

Amazon on where the company's health care bets are headed next

ChatGPT in medicine: STAT answers readers' burning questions

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Tori Bowie and the unacceptable rates of Black maternal death

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Trump demands the U.S. pay no more for drugs than other countries … again

Wearables generate powerful data but its not useful to doctors, yet

United colonoscopy coverage change 'may cost lives,' doctors say

Cytokinetics CEO stresses company can launch heart drug on its own

hotspot

Amazon on where the company's health care bets are headed next

With measles on the rise, a personal story of a devastating disease

Amazon on where the company's health care bets are headed next

AstraZeneca chief proposes a novel edit to the drug pricing bill

NIH nominee Bertagnolli will get October confirmation hearing

Covid hospitalizations on the rise, Humana says

explore

knowledge

leisure time

explore